Recognizing and treating patients with Ewing sarcoma
- PMID: 37668491
- DOI: 10.1097/01.JAA.0000937324.58262.55
Recognizing and treating patients with Ewing sarcoma
Abstract
This article reviews the cause, presentation, diagnosis, and management of Ewing sarcoma, the second most common primary bone malignancy in children and young adults. Recent research has provided advances in understanding the cause of Ewing sarcoma as well as improved treatment regimens. However, much is still unknown and additional research is needed to continue to improve the overall prognosis, which ranges from 70% to 80% 5-year survival for patients with localized disease. Improving clinician knowledge about Ewing sarcoma will help shorten time to diagnosis and improve survival rates.
Copyright © 2023 American Academy of Physician Associates.
References
-
- Grünewald TGP, Cidre-Aranaz F, Surdez D, et al. Ewing sarcoma. Nat Rev Dis Primers . 2018;4(1):5.
-
- Hui JY. Epidemiology and etiology of sarcomas. Surg Clin North Am . 2016;96(5):901–914.
-
- Doyle LA. Sarcoma classification: an update based on the 2013 World Health Organization classification of tumors of soft tissue and bone. Cancer . 2014;120(12):1763–1774.
-
- Gaspar N, Hawkins DS, Dirksen U, et al. Ewing sarcoma: current management and future approaches through collaboration. J Clin Oncol . 2015;33(27):3036–3046.
-
- Gargallo P, Yáñez Y, Juan A, et al. Review: Ewing sarcoma predisposition. Pathol Oncol Res . 2020;26(4):2057–2066.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical